Search

The New Delhi Declaration’s policy commitments in the health sector emphasise the role of the G20 in revising the existing financial and global heal

The G20 has the potential to leverage its influence and resources to address the root causes of zoonotic diseases through joint initiatives and take p

Policies and tailored interventions need to be adopted to mitigate the growing global threat of antimicrobial resistance

India must redouble its efforts in the WTO to have the TRIPS waiver extended to cover therapeutics and diagnostics and use its G20 Presidency and the

Despite facing several challenges, Delhi’s mohalla clinics have been instrumental in providing healthcare services to the poor and underserved.

The phase of mandatory approvals and vastly expanded scope under the rulebook heralds a new era for the regulation of medical devices.

Globally, healthcare has made great strides in making vaccines, diagnostics and therapeutics available to more people. Yet, infectious diseases continue to pose a significant threat in many parts of the world, and the SARS, Ebola, and Zika crises are only a few of the recent outbreaks that draw attention to the weaknesses of public health systems. In India, the recent epidemics of Nipah virus and acute encephalitis syndrome call attention to the

In an effort to facilitate the digitisation of the country’s healthcare systems, India released a National Digital Health Blueprint in January 2020, which provides a detailed framework for a “Federated National Health Information System.” This brief makes a case for expanding the scope of the blueprint to include digital therapeutics, digital diagnostics, and telemedicine. It proposes a “National Digital Health Blueprint 2.0,” with dive

संयुक्त पुढाकारांद्वारे झुनोटिक रोगांच्या मूळ कारणांना संबोधित करण्यासाठी आणि जागतिक स्तरावर प्रतिबंधात्मक उपाययोजना करण्याच्या दृष्टीने जी २० कडे त्याच्या प्रभा�